LLY

1,073.71

-0.24%↓

JNJ

207.38

-0.2%↓

ABBV

230

-0.06%↓

UNH

329.54

+0.55%↑

AZN

92.78

+0.3%↑

LLY

1,073.71

-0.24%↓

JNJ

207.38

-0.2%↓

ABBV

230

-0.06%↓

UNH

329.54

+0.55%↑

AZN

92.78

+0.3%↑

LLY

1,073.71

-0.24%↓

JNJ

207.38

-0.2%↓

ABBV

230

-0.06%↓

UNH

329.54

+0.55%↑

AZN

92.78

+0.3%↑

LLY

1,073.71

-0.24%↓

JNJ

207.38

-0.2%↓

ABBV

230

-0.06%↓

UNH

329.54

+0.55%↑

AZN

92.78

+0.3%↑

LLY

1,073.71

-0.24%↓

JNJ

207.38

-0.2%↓

ABBV

230

-0.06%↓

UNH

329.54

+0.55%↑

AZN

92.78

+0.3%↑

Inicio・Lista de Acciones・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Abierto

SectorSanidad

26.13 -2.35

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

25.18

Máximo

26.51

Métricas clave
By Trading Economics
Ingresos	-10M -67M
BPA	-1.01
Margen de beneficios	-7,753.425
Empleados	186
EBITDA	-9.8M -73M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+104.99% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	307M 1.8B
Apertura anterior	28.48
Cierre anterior	26.13

Noticias sobre sentimiento de mercado

By Acuity

50%

152 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

18.91 / 20.63 Soporte y Resistencia

Celldex Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 dic 2025, 21:41 UTC

Adquisiciones, fusiones, absorciones

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

24 dic 2025, 14:57 UTC

Adquisiciones, fusiones, absorciones

Accenture to Acquire Cabel Industry from Fibonacci Group

25 dic 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25 dic 2025, 23:40 UTC

Charlas de Mercado

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25 dic 2025, 00:20 UTC

Adquisiciones, fusiones, absorciones

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24 dic 2025, 22:22 UTC

Adquisiciones, fusiones, absorciones

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 dic 2025, 21:26 UTC

Adquisiciones, fusiones, absorciones

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24 dic 2025, 19:35 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

24 dic 2025, 19:35 UTC

Charlas de Mercado

Treasury Yields Decline Ahead of Christmas -- Market Talk

24 dic 2025, 19:09 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Global Equities Roundup: Market Talk

24 dic 2025, 19:09 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24 dic 2025, 19:06 UTC

Charlas de Mercado

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

24 dic 2025, 19:03 UTC

Charlas de Mercado

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

24 dic 2025, 17:20 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

24 dic 2025, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

24 dic 2025, 17:08 UTC

Adquisiciones, fusiones, absorciones

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 dic 2025, 16:53 UTC

Adquisiciones, fusiones, absorciones

Nike Climb Boosts Dow, S&P 500 -- WSJ

24 dic 2025, 16:31 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

24 dic 2025, 16:28 UTC

Adquisiciones, fusiones, absorciones

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

24 dic 2025, 16:17 UTC

Charlas de Mercado

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

24 dic 2025, 15:33 UTC

Adquisiciones, fusiones, absorciones

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

24 dic 2025, 15:30 UTC

Adquisiciones, fusiones, absorciones

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dic 2025, 15:19 UTC

Adquisiciones, fusiones, absorciones

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dic 2025, 14:49 UTC

Adquisiciones, fusiones, absorciones

Mexico's Ollamani Sells Stake in Azteca Stadium

24 dic 2025, 14:19 UTC

Charlas de Mercado

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

24 dic 2025, 14:08 UTC

Adquisiciones, fusiones, absorciones

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dic 2025, 14:06 UTC

Charlas de Mercado

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

24 dic 2025, 13:24 UTC

Charlas de Mercado

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

24 dic 2025, 12:59 UTC

Adquisiciones, fusiones, absorciones

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 dic 2025, 12:51 UTC

Adquisiciones, fusiones, absorciones

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

Comparación entre iguales

Cambio de precio

Celldex Therapeutics Inc previsión

Precio Objetivo

By TipRanks

104.99% repunte

Estimación a 12 Meses

Media 55 USD 104.99%

Máximo 90 USD

Mínimo 24 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Celldex Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

10 ratings

Comprar

Mantener

Vender

De acuerdo con 10 analistas que ofrecen calificaciones bursátiles a para Celldex Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

18.91 / 20.63Soporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimiento

By Acuity

152 / 374 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.